CD274 and systemic lupus erythematosus: We believe an in-depth understanding of the relationship between the pathological process of AS and immune response, exploration of the mechanism of the PD-1/PD-L1 signaling pathway, and using of this pathway as a potential therapeutic target for AS in SLE might shed new light on clinical management of AS in SLE and prevention of cardiovascular events in SLE.